TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EVMN

Evommune, Inc.

Healthcare · Biotechnology

9.70$ +3.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement EVMN
Line item 2023 2024 2025
+40.0% +85.7%
+28.7% +7.9%
+42.8% +127.6%
+100.8% +15.3%
+80.9% +24.2%
-41.4% -79.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?